Ripretinib for treating advanced gastrointestinal stromal tumour after 3 or more treatments
Technology appraisal guidance
Reference number: TA881
Published:
The timelines for this appraisal moving forward have now been confirmed.
The deadline for evidence submission is Tuesday 17 May 2022. The first appraisal committee meeting discussion will now be held on 2 November 2022.